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In this issue of the Biomedical Journal, we highlight a review revealing that the effect of
autophagy, reactive oxygen species, and antioxidants in cancer may be a question of
timing and context. We also discuss original research showing that the prevalence of cleft
lip with or without palate in Taiwan has declined over the past 20 years, and what this
might mean in terms of trends in abortion. Finally, we also learn about risk factors for
recurrent hospital-acquired infection with multi-drug resistant bacteria, and the value of
dental screening for patients with tinnitus.Spotlight on reviews
The dual role of ROS, antioxidants and autophagy in cancer
Reactive oxygen species (ROS), including peroxides, superox-
ide and hydroxyl radicals, are a by-product of normal cell
metabolism and important cell signaling molecules; yet, they
are perhaps more infamously known for the role in ageing [1]
and disease [2]. In excess, these molecules can cause irre-
versible damage to lipids, DNA and proteins. If ROS wreak
havoc, cells can ‘clean up’ the mess they create through
autophagy, in which damaged cellular components are
degraded in lysosomes. Although these quality control path-
ways are generally thought to protect cells against the
harmful effects of ROS, this view might not be so clear cut asg Gung University.
ublishing services by Else
s/by-nc-nd/4.0/).explained by Hjelmeland and Zhang [3] in this issue of the
Biomedical Journal.
The link between ROS and cancer initiation is a long-
standing one. Besides the high levels of ROS in obvious
environmental carcinogens such as cigarette smoke [4], ROS
have been shown to be critical for the transformation of cells
mediated by oncogenes or loss of tumor suppressors. For
example, the downregulation of p53 leads to increased ROS
levels and antioxidant-related drugs inhibit tumor formation
in mice lacking this gene [5]. However, every tumor is
unique, and the role of ROS and antioxidants can differ
depending on the genetic, epigenetic, and microenviron-
mental variation present. Indeed, mouse embryonic fibro-
blasts expressing mutant G12V K-Ras have low levels of ROS
[6], and in another model, high levels of antioxidant pro-
duction through mechanisms such as the upregulation of
Nrf2 offers a survival advantage [7]. Thus, the notion thatvier B.V. This is an open access article under the CC BY-NC-ND
Fig. 1 e Autophagy and ROS in tumor initiation and progression. In normal cells, the accumulation of ROS promotes tumor
initiation. Autophagy removes ROS-damaged cellular components, thus protecting against tumorigenesis. However, in
established tumor cells, the removal of these components by autophagy offers certain survival advantages and may lead to
chemoresistance. Figure adapted from Hjelmeland et al. [3].
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extent on context.
This lack of a simple dichotomy also applies somewhat to
autophagy. The accumulation of damaged proteins or or-
ganelles leads to the generation of autophagosomes, which
encapsulate the faulty cell contents and deliver them to ly-
sosomes for degradation. This process involves over 30
proteins and many cellular signaling pathways [8], the
perturbation of which leads to tumorigenesis [9]. This makes
sense because autophagy suppresses chronic tissue damage
and maintains genomic stability, but again the relationship
is complex. For example, depending on cell context, auto-
phagy may promote tumor growth by suppressing the p53
response, sustaining metabolic homeostasis and survival in
stress and preventing the diversion of tumors to benign
oncocytomas [10]. In light of these findings, autophagy in-
hibitors such as chloroquine have been tested in cancer
therapy [11].
Thus, the effect of redox status and autophagy in cancer
appears to be a question of context, and in particular, timing
[Fig. 1]. Although high levels of ROS and defects in autophagy
promote cancer initiation, tumor cells with established
genome mutations or rearrangements depend strongly on
antioxidants and autophagy to gain survival advantages. How
exactly to hit the tumor where it hurts will thus depend on
complex phenotyping as part of the continuation of the quest
to develop personalized treatments.Spotlight on original articles
Drop in incidence of cleft lip/palate in Taiwan
Multiple factors have been linked to the development of cleft
defects, including genetics, socio-economic status and in
particular, environmental factors such as smoking, low folate
consumption and drinking alcohol. While awareness aboutthe dangers of smoking and drinking during pregnancy has
increased over the years, so too has the use and accuracy of
prenatal diagnosis by sonography [12]. In this issue of the
Biomedical Journal, Chang et al. [13] report a drop in the inci-
dence of cleft defects in Taiwan over the past 20 years, and
suggest that this is due to an increase in the termination of
fetuses with cleft defects.
Cleft lip and/or palate are the most common congenital
craniofacial anomalies with an incidence of 1:700 to 1:1000
births depending on the population. These defects arise be-
tween the sixth and ninth week of pregnancy, when the tis-
sues of the mouth and face are formed. Their treatment
requires a multidisciplinary approach, involving surgery dur-
ing the first sixth months of life, followed by subsequent
surgical procedures and visits to a speech therapist, ortho-
dontist, psychologist and specialist nurse.
Cleft lip was first diagnosed prenatally by sonography in
1981 [14]. Today, using 3D sonography, cleft lip with or
without plate can be detected with an accuracy of 86e100%
whereas a cleft palate alone remains difficult to diagnose
before birth [15]. This improvement in technology has created
a situation in which it is now possible in many countries to
diagnose a cleft lip and terminate a pregnancy during the
second trimester, all within the realm of the law. In Taiwan,
abortion is legally permitted before 24 weeks of pregnancy if
the fetus has severe congenital anomalies or causes detri-
mental effect to the mother. In 1995, following the establish-
ment of National Health Insurance, prenatal sonography
screening became readily available to Taiwanese women on a
large scale for the first time.
To investigate the impact of widely available prenatal
diagnosis, Jung et al. determined the rate of cleft defects in
Taiwan between 1994 and 2013, during the introduction of
National Health Insurance. They collected data from the two
only Craniofacial centers in Taiwanwhere patients with clefts
are referred. Out of nearly five million live births in Taiwan
during the 20 year period, a total of 7282 new patients with
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nificant decrease in the incidence of cleft lip with palate of
2.9% during the period, but there was a small increase in the
incidence of cleft palate alone. Out of the 148 children treated
for cleft lip with or without palate between 2009 and 2012, 73%
had been diagnosed prenatally.
Although several factors may account for the decrease in
cleft defects in Taiwan in recent years, a decrease specif-
ically in the rate of cleft lip but not cleft palate alone sug-
gests that prenatal diagnosis has played a prominent role.
The aim of prenatal screening is not to increase the termi-
nation rate but to provide information to ensure the best
care of both mother and fetus. Whether a prenatal diag-
nosis of cleft defect leads to termination largely depends on
cultural factors and religion. A slowly declining trend in the
incidence of cleft lip with or without palate and a stable
incidence of cleft palate alone has been reported in other
countries such as the Netherlands [16], where screening is
carried out and abortion is permitted until the end of the
second trimester. However, in a survey of Argentine parents
of children with craniofacial clefts, none said that they
would have terminated the pregnancy had they known
about the condition, and half said that abortion should not
be an option for any couple expecting a child [17].
In Taiwan, craniofacial defects are not well accepted and
there is a relatively low stigma surrounding abortion. Yet, the
decision to terminate a pregnancy second to a non-life
threatening deformity is a complicated one, which is even
reflected in the under-reporting of such terminations in some
countries [18]. Technology in prenatal diagnosis is advancing.
Now we must decide how to use it wisely.Also in this issue:
News and perspectives
Road to a Nobel Prize
Chen [19] honors the awardees of the 2015 Nobel Prize in
Physiology or Medicine by describing the route leading to the
discovery of the anti-parasitic drugs avermectin and artemi-
sinin, which have revolutionized treatment of roundworms
and malaria, respectively.
Review article
Visualizing retinal diseases in real time
In this review, Murthy et al. [20] discuss advances in optical
coherence tomography, a non-invasive imaging technique
that uses light waves to take cross-sectional pictures of the
retina, and describe how this technique has become indis-
pensable in the diagnosis andmanagement of retinal diseases.
Original articles
Anti-EGFR therapy in the face of resistance
Lung adenocarcinoma is a deadly disease with a poor prog-
nosis. Some patients with particular mutations in the
epidermal growth factor (EGFR) respond to anti-EGFR targeted
therapies; however, most people eventually acquireresistance to these drugs [21]. If new lesions appear then
treatment should be altered, yet the condition of some pa-
tients deteriorates rapidly after the withdrawal of anti-EGFR
agents, despite acquired resistance [22]. In this retrospective
study of 102 patients, Hsu et al. [23] find no clear benefit to
discontinuing EGFR therapy following acquired resistance.
Diabetes is a risk factor for recurrent infection with multidrug
resistant bacteria
Multidrug-resistant A. baumannii (MDR-AB) is becoming an
increasingmenace in hospital environments and is a frequent
case of healthcare-associated infections [24]. In some pa-
tients, the infection comes back despite appearing to be clin-
ically eradicated. To identify factors that might promote
recurrent infections, Lin et al. [25] retrospectively analyzed
106 patients with pulmonary MDR-AB infection, and identify
diabetes mellitus as a risk factor for relapse of infection.
Dental screening for tinnitus patients
Tinnitus is a ringing in the ears which is readily perceived by
patients but cannot be objectively measured. In clinical
practice, the condition is often associated with problems in
the jaw ormuscles of the face (temporomandibular disorders),
suggesting that a dental exam should be an integral part of the
care of tinnitus patients. Now, Di Berardino [26] et al. use T-
scan III occlusal imaging to measure occlusal stability in in-
dividuals with or without tinnitus. Their findings suggest a
useful diagnostic tool to determine whether patients with
tinnitus should be referred to a dentist.
Optimal sedation approach for endoscopy technique in an
outpatient setting
Endoscopic retrograde cholangiopancreatography (ERCP) is a
specialized technique combing endoscopy and X-rays to di-
agnose and treat problems of the bile and pancreatic ducts.
ERCP can be performed in an outpatient setting with different
sedation techniques being applied in different centers. In this
prospective clinical trial of 49 patients, Akhondzadeh et al. [27]
compare combinations of anesthetics and analgesics among
patients undergoing ERCP outside the operating room and
found that propofoleketamine was associated lower levels of
pain and apnea than propofolefentanyl.
Brief communication
Mucormycetes infection despite functioning immune system
Mucormycosis is a serious but rare fungal infection caused by
molds called mucormycetes. It usually infects individuals
with a weakened immune, but in this case report, Bhatta-
charya et al. [28] describe the unusual presentation of
esophageal mucormycosis in an immunocompetent infant.
Letter to the editor
Challenges to increasing the use of contraceptives in Northern
India
Roy [29] comments on an article by Deepti Choudhary et al.
[30] in a recent issue of the Biomedical Journal in which the
authors analyzed patterns of contraceptive behavior in
Northern India. Roy asks Choudhary to elaborate on why
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use contraceptives despite knowledge of their existence. In
her reply, Choudhary [31] lists several reasons, including
inability to choose appropriate method, unavailability of
methods, lack of knowledge about how to use them, and fear
of side-effects.r e f e r e n c e s
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